CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 33 filers reported holding CARDIOME PHARMA CORP in Q3 2016. The put-call ratio across all filers is 14.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | -100.0% | 358 | -96.8% | 0.00% | -100.0% |
| Q3 2017 | $23,000 | -79.6% | 11,124 | -55.8% | 0.00% | -80.0% |
| Q2 2017 | $113,000 | +94.8% | 25,176 | +30.6% | 0.01% | +66.7% |
| Q1 2017 | $58,000 | +5700.0% | 19,280 | +4843.6% | 0.00% | – |
| Q4 2016 | $1,000 | – | 390 | +34.5% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 290 | -84.7% | 0.00% | -100.0% |
| Q2 2016 | $9,000 | -77.5% | 1,892 | -62.2% | 0.00% | -66.7% |
| Q4 2015 | $40,000 | – | 5,010 | +6009.8% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 82 | -96.5% | 0.00% | -100.0% |
| Q2 2015 | $22,000 | +2100.0% | 2,350 | +1842.1% | 0.00% | – |
| Q1 2015 | $1,000 | -91.7% | 121 | -90.4% | 0.00% | -100.0% |
| Q4 2014 | $12,000 | – | 1,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,241,550 | $7,520,000 | 4.03% |
| Tamarack Advisers, LP | 1,875,000 | $4,350,000 | 2.07% |
| CLOUGH CAPITAL PARTNERS L P | 2,075,663 | $4,816,000 | 0.46% |
| Rock Springs Capital Management LP | 1,200,000 | $2,784,000 | 0.12% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,192,034 | $9,726,000 | 0.08% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $7,174,000 | 0.02% |
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |
| SCOTIA CAPITAL INC. | 19,120 | $44,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,200 | $118,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 700 | $2,000 | 0.00% |